INS-05-001: A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain
www.clinicaltrials.gov listing
www.cancer.gov listing
INS-06-007: Open-Label Multi-Center Safety Trial of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain
www.clinicaltrials.gov listing
www.cancer.gov listing
|
